Valuation: LifeMD, Inc.

Market Cap 22Cr 19Cr 18Cr 16Cr 31Cr 2.09TCr 32Cr 212.12Cr 82Cr 1.03TCr 82Cr 81Cr 3.53TCr P/E 2026 *
-16.6x
P/E 2027 * 61.1x
Enterprise Value 22Cr 19Cr 18Cr 16Cr 31Cr 2.09TCr 32Cr 212.12Cr 82Cr 1.03TCr 82Cr 81Cr 3.53TCr EV / Sales 2026 *
0.99x
EV / Sales 2027 * 0.84x
Free-Float
85.35%
Yield 2026 *
-
Yield 2027 * -
1 day+7.27%
1 week+8.22%
Current month+17.92%
1 month+5.18%
3 months+36.03%
6 months+42.82%
Current year+42.82%
1 week 3.9
Extreme 3.9
5.1
1 month 3.9
Extreme 3.9
5.23
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
13.09
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 01/08/2025
Director of Finance/CFO 57 16/03/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 57 20/06/2023
Chairman 65 -
Director/Board Member 51 06/11/2020
Date Insider Type Main position Quantity % Market Cap.
11/05Free

Chief Financial Officer

3,37,500 0.7035%
30/03Free

Responsable ventes & marketing

2,00,000 0.4155%
09/12Sell

Executive/Senior Manager

15,000 0.0312%
Change 5-day change 1-year change 3-year change Capi.($)
+7.27%+8.22%-62.91%+11.95% 22Cr
+4.62%+19.45%-31.87%-2.52% 2.99TCr
+1.51%+15.05%-26.89%+213.73% 1.46TCr
+2.44%+4.92%-14.77%+62.74% 569.67Cr
-8.94%-19.89% - - 264.85Cr
+5.52%+7.27% - - 211.52Cr
+2.62%+8.96%+43.77%-41.59% 190.69Cr
-6.27%-1.28%-22.73% - 132.77Cr
+3.19%+14.65%-30.28%+268.40% 80Cr
-2.11%-2.40%-43.28%-61.22% 76Cr
Average +0.96%+4.69%-23.62%+64.50% 600.19Cr
Weighted average by Cap. +2.27%+10.59%-26.22%+64.88%

Financials

2026 *2027 *
Net sales 22Cr 19Cr 18Cr 17Cr 31Cr 2.11TCr 32Cr 214.52Cr 83Cr 1.04TCr 83Cr 82Cr 3.57TCr 26Cr 23Cr 21Cr 20Cr 37Cr 2.48TCr 38Cr 252.06Cr 98Cr 1.22TCr 98Cr 96Cr 4.2TCr
Net income -1.31Cr -1.15Cr -1.05Cr -98.13L -1.86Cr -124.85Cr -1.89Cr -13Cr -4.91Cr -61Cr -4.92Cr -4.82Cr -211Cr 35.74L 31.23L 28.68L 26.75L 50.7L 34Cr 51.56L 3.45Cr 1.34Cr 17Cr 1.34Cr 1.31Cr 58Cr
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
Employees
350
Date Price Change Volume
03/26/03 $4.870 +7.27% 16,55,936
01/26/01 $4.540 +9.93% 19,03,807
30/26/30 $4.130 -1.67% 14,03,112
29/26/29 $4.200 +1.69% 14,12,801
26/26/26 $4.130 -1.67% 15,60,447
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
4.865USD
Average target price
9.875USD
Spread / Average Target
+102.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock